livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
livmarli 9,5 mg/ml
millmount healthcare limited - irlanda - maralixibatum - sol. orala - 9,5mg/ml - terapia vezicii biliare alte medicamente pentru terapia vezicii
quviviq
idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - tulburări de inițiere și întreținere a somnului - psiholeptice - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
dibazol solutie injectabila 1%
farmaco sa, im - bendazolum - solutie injectabila - 1%
ditilin-darnita solutie injectabila 20 mg/ml
darnita sap, firma farmaceutica - suxamethonii iodidum - solutie injectabila - 20 mg/ml
hidrotartrat de platifilina solutie injectabila 0,2%
farmaco sa, im - platyphyllini hydrotartras - solutie injectabila - 0,2%
lidocain-zdorovie solutie injectabila 10%
zdorovie srl, companie farmaceutica - lidocaini hydrochloridum - solutie injectabila - 10%
lidocain-zdorovie solutie injectabila 2%
zdorovie srl, companie farmaceutica - lidocaini hydrochloridum - solutie injectabila - 2%
muscoflex capsule 4 mg
bilim pharmaceuticals a.s. - thiocolchicosidum - capsule - 4 mg
muscoflex crema 0,25%
bilim pharmaceuticals a.s. - thiocolchicosidum - crema - 0,25%